Abstract


Abstract will open in

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Abstract submission will open on September 9th 2019 and close on December 19th 2019

Abstract submission


Participants interested in presenting papers at the Oral and Poster sessions are invited to submit their abstracts.
All abstracts will be reviewed by the Abstract Reviewing Committee.
The highest ranked abstracts among those submitted for oral presentation, may be considered by the Scientific Program Committee for presentation during Symposia instead of Oral Communication Sessions.

Rools for subimission: 

  • The deadline for abstract submission is December 19th 2019.
  • Presenting authors will be notified whether their abstract has been accepted by February 10th 2020.
  • Authors whose abstracts have been accepted must register for the Congress and pay the registration fee by February 27th, 2020. Failure to do so will result in exclusion from the Scientific Program and the Book of Abstracts.
  • The abstract cannot be longer than 2000 characters and must be plain text: it is not possible to include tables and images, but you may insert data in the text of the abstract. Abstracts for free communications and posters should be divided into: Objective – Methods – Results – Conclusions.

List of Topics
for Abstract submission


1. General menopause including
  • Epidemiology, basic science and clinical research
  • Diagnosis of menopause
  • Symptoms of menopause including vasomotor symptoms
  • Biochemical prediction of age at menopause
  • Hormone and non-hormonal therapy
  • Premature ovarian insufficiency
  • The menopause after cancer
  • Other topics related to the menopause
2. Vulvovaginal atrophy/genitourinary syndrome of menopause
  • Urogynecology – including incontinence and prolapse
3. Hormones and hormone action
  • Hormones and hormone receptor signaling mechanisms
  • Biological actions of sex steroids
  • Selective hormone receptor modulators
  • Novel treatments and regimens
4. Hormones and the metabolism including
  • Obesity
  • Metabolic syndrome
  • Insulin resistance, diabetes and yslipidemia
  • Other topics related to hormones and the metabolism
5. Sexual function including
  • Epidemiology, basic science and clinical research
  • Treatment options – psychological and medical approaches
6. Menopause and cardiovascular system including
  • Epidemiology, basic science and clinical research
  • Hormones and coronary heart disease
  • Hormones and thrombosis
  • Hormones and cerebrovascular disease
  • Other cardiovascular topics
7. Menopause and the brain including
  • Neurosteroids and actions
  • Cognitive function
  • Sleep and sleep disorders
  • Alzheimer’s disease and other neurodegenerative disorders
8. Mood and mental disorders including
  • Epidemiology, basic science and clinical research
  • Hormonal and non-hormonal treatment of mood disorders (including perimenopausal and premenstrual depression)
  • Schizophrenia and other mental disorders
9. Musculoskeletal health including
  • Bone loss and osteoporosis
  • Sarcopenia
  • Pharmacological and non-pharmacological fracture prevention
10. Breast health including
  • Breast and breast cancer biology
  • Breast cancer epidemiology
  • Hormone therapy and breast cancer
  • Breast cancer screening and diagnosis
  • Tolerance and aromatase inhibitor-related site effects
  • Adjuvant bisphosphonates
  • Other topics related to breast and breast cancer
11. Gynecology including
  • Abnormal uterine bleeding
  • Management of fibroids – medical and surgical Endometriosis (in perimenopause and consequences of surgery)
  • PCOS – implications for menopause
  • Endometrial hyperplasia and cancer
  • Vulval and vaginal conditions – VVA/GSM and other disorders
  • Diagnostic gynecology
  • Urogynecology – including incontinence and prolapse
12. Other oncology including
  • Hormones and non-gynecological cancer
  • Screening, diagnosis and treatment of women
  • Treatment consequences in relation to the menopause
  • Novel non hormonal treatment regimens